Altai Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Altai Capital Management’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-82,097	Closed	-$152K	–	8
2022 Q3	$152K	Sell	82,097 -17,903	-18%	-$53.4K	0.15%	8
2022 Q2	$307K	Hold	100,000	–	–	0.23%	10
2022 Q1	$722K	Hold	100,000	–	–	0.49%	11
2021 Q4	$1.64M	Hold	100,000	–	–	0.98%	11
2021 Q3	$995K	Hold	100,000	–	–	0.73%	13
2021 Q2	$998K	Hold	100,000	–	–	0.81%	9
2021 Q1	$996K	Buy	+100,000	New	+$1.03M	0.84%	7

Other funds holding PRDS

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return